Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Lydia Meziani

5PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyTumour immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

Sort by Publication Date:
|Jun 30, 2025
Low-dose radiotherapy enhances the efficacy of PD-L1 blockade and induces the abscopal effect.

Pierre-Antoine Laurent, Liu Shi, Lisa Bouarroudj

|Oct 13, 2024
Non-homogenous intratumor ionizing radiation doses synergize with PD1 and CXCR2 blockade.

Paul Bergeron, Morgane Dos Santos, Lisa Sitterle

|Jun 03, 2023
Optimal dosing regimen of CD73 blockade improves tumor response to radiotherapy through iCOS downregulation.

Lydia Meziani, Marine Gerbé de Thoré, Céline Clémenson

|Mar 18, 2022
TGFβ receptor inhibition unleashes interferon-β production by tumor-associated macrophages and enhances radiotherapy efficacy.

Pauline Hamon, Marine Gerbé De Thoré, Marion Classe

|Jun 24, 2020
Dual oxidase 1 limits the IFNγ-associated antitumor effect of macrophages.

Lydia Meziani, Marine Gerbé de Thoré, Pauline Hamon

Pageof 1

Frequent Collaborators

4 joint publications

Michele Mondini

3 joint publications

Eric Deutsch

1 joint publications

Paul Bergeron

1 joint publications

Georges Tarlet

1 joint publications

Kevin Berthelot

1 joint publications

Pierre-Antoine Laurent

1 joint publications

Antonin Levy

Frequent Collaborators

4 joint publications

Michele Mondini

3 joint publications

Eric Deutsch

1 joint publications

Paul Bergeron

1 joint publications

Georges Tarlet

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

611
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on : Jan 29, 2019

10.1K
See more related videos

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

611
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on : Jan 29, 2019

10.1K
See more related videos